Hrubá marže společnosti SinoMab BioScience
Jaká je hodnota metriky Hrubá marže společnosti SinoMab BioScience?
Hodnota metriky Hrubá marže společnosti SinoMab BioScience Limited je 78.59%
Jaká je definice metriky Hrubá marže?
Hrubá marže (Gross margin) je rozdíl mezi příjmy a náklady na prodané zboží dělený příjmy a vyjádřený v procentech.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Hrubá marže společností v sektoru Health Care sektor na HKSE ve srovnání se společností SinoMab BioScience
Čemu se věnuje společnost SinoMab BioScience?
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is Phase I clinical trial for the treatment of RA, SLE, pemphigus, multiple sclerosis, and other immunological diseases. Its products under preclinical stage comprise SM17 for the treatment of asthma and idiopathic pulmonary fibrosis; SM09 that is used for the treatment of NHL and RA; SM06 for use in treating RA, SLE, and SS; and TNF2 for the treatment of RA. The company operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.
Firmy s metrikou hrubá marže podobnou společnosti SinoMab BioScience
- Hodnota metriky Hrubá marže společnosti Rua Life Sciences Plc je 78.54%
- Hodnota metriky Hrubá marže společnosti Acrow Formwork and Construction Services je 78.56%
- Hodnota metriky Hrubá marže společnosti Uniti je 78.57%
- Hodnota metriky Hrubá marže společnosti LifeTech Scientific je 78.57%
- Hodnota metriky Hrubá marže společnosti Servicenow Dl ,001 je 78.59%
- Hodnota metriky Hrubá marže společnosti ServiceNow Inc je 78.59%
- Hodnota metriky Hrubá marže společnosti SinoMab BioScience je 78.59%
- Hodnota metriky Hrubá marže společnosti Tera Software je 78.59%
- Hodnota metriky Hrubá marže společnosti i-nexus Global plc je 78.59%
- Hodnota metriky Hrubá marže společnosti F-Secure Oyj je 78.60%
- Hodnota metriky Hrubá marže společnosti Magellan je 78.61%
- Hodnota metriky Hrubá marže společnosti Prozone Intu Properties je 78.63%
- Hodnota metriky Hrubá marže společnosti Pandora AS je 78.63%